Leadership

Helge Zieler, PhD

Chief Executive Officer

Michele Rubino, MBA

Chief Business Officer

Page Daniels, PhD

Chief Scientific Officer

COLLECTIVELY WE HAVE

  • An extensive track record of successful project and business execution
  • Raised >$45M at Primordial Genetics and Primrose Bio
  • 11 issued patents, 30 patent applications, 1 publication
  • Created genetic technologies and enzyme evolution platforms that derisk Stelli Bio
  • Developed mRNA manufacturing enzymes and brought to market in 2025
  • Executed 3 year pharma manufacturing partnership
  • Negotiated 2023 Primordial Genetics – Pfenex merger to create Primrose Bio